Morocco medicine price database

RIVAROX PROMOPHARM

2,5 MG · comprimes enrobes · box 30

RIVAROXABAN

Historical reference: this presentation is not marketed, withdrawn or suspended according to the source. Its listed price does not establish availability.

Reference dated : 2026-06-01. Confirm price and availability with a pharmacist.

Public price

105,70 MAD

Laboratory

PROMOPHARM

What is this medicine?

French reference leaflet: RIVAROXABAN ZENTIVA 2,5 mg, comprimé pelliculé. Confirm indications in Morocco with a pharmacist.

Pharmacotherapeutic class: Antithrombotics, Direct inhibitors of factor Xa, ATC code: B01AF01. RIVAROXABAN ZENTIVA has been prescribed to you because · you have been diagnosed with acute coronary syndrome (a set of diseases including heart attack and unstable angina, corresponding to a type of severe chest pain) and because your blood test showed an increase in cardiac enzymes. In adults, RIVAROXABAN ZENTIVA reduces the risk of having another heart attack or dying from a disease related to the heart or blood vessels. RIVAROXABAN ZENTIVA will be prescribed to you with another medicine. Thus, your doctor will also ask you to take: o acetylsalicylic acid or o acetylsalicylic acid plus clopidogrel or ticlopidine. or · you have been diagnosed with a high risk of presenting a blood clot due to coronary artery disease or peripheral artery disease that causes symptoms. In adults, RIVAROXABAN ZENTIVA reduces the risk of presenting blood clots (atherothrombotic events). RIVAROXABAN ZENTIVA will be prescribed to you with another medicine. Thus, your doctor will also ask you to take acetylsalicylic acid. In certain cases, if you receive RIVAROXABAN ZENTIVA after a procedure to clear a narrowed or blocked artery in your leg to restore blood circulation, your doctor may also prescribe clopidogrel to be taken in addition to acetylsalicylic acid for a short duration. RIVAROXABAN ZENTIVA contains an active substance called rivaroxaban and belongs to a class of medicines called antithrombotics. It works by blocking a blood clotting factor (factor Xa), thereby reducing the tendency of the blood to form clots.

Hospital price

66,10 MAD

Commercial status

Non Commercialisé

References and update dates

Historical reference; confirm the price with a pharmacist.

Base de données publique des médicaments (France) · 2026-09-29 · Licence Ouverte

Read medical reference

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-01: 105,70 MAD

Referenced presentations and strengths

Same ingredient, strength and form

This grouping does not establish interchangeability.

Other strengths and forms

Routes and instructions may differ.